Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
The global burden of group A streptococcal diseases.
- J. Carapetis, A. Steer, E. Mulholland, M. Weber
- The Lancet. Infectious diseases
- 1 November 2005
The need to reinforce current control strategies, develop new primary prevention strategies, and collect better data from developing countries for most diseases is highlighted, as GAS is an important cause of morbidity and mortality. Expand
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades. Expand
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.
- A. Steer, I. Law, L. Matatolu, B. Beall, J. Carapetis
- Biology, Medicine
- The Lancet. Infectious diseases
- 1 October 2009
On the basis of the available data, the current formulation of the experimental multivalent emm vaccine would provide good coverage in high-income countries, particularly USA, Canada, and Europe, but poor coverage in Africa and the Pacific, and only average coverage in Asia and the Middle East. Expand
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline
The standardized criteria for RHD aim to permit rapid and consistent identification of individuals with RHD without a clear history of acute rheumatic fever and hence allow enrollment into secondary prophylaxis programs. Expand
Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015
- D. Watkins, C. Johnson, +17 authors G. Roth
- The New England journal of medicine
- 23 August 2017
The health‐related burden of rheumatic heart disease has declined worldwide, but high rates of disease persist in some of the poorest regions in the world. Expand
Scabies in the developing world--its prevalence, complications, and management.
- R. Hay, A. Steer, D. Engelman, Shelley F. Walton
- Clinical microbiology and infection : the…
- 1 April 2012
The purpose of this review is to provide an update on the current position of scabies with regard to its complications and control in resource-poor countries. Expand
Prevalence of scabies and impetigo worldwide: a systematic review.
Overall, scabies prevalence was highest in the Pacific and Latin American regions, and was substantially higher in children than in adolescents and adults, while Impetigo was common, particularly in children, with the highest prevalence in Australian Aboriginal communities. Expand
Acute rheumatic fever and rheumatic heart disease
Progress in developing group A streptococcal vaccines and an increased focus on the lived experience of those with RHD and the need to improve quality of life give cause for optimism that progress will be made against this neglected disease. Expand
Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors
- A. Steer, J. Carapetis, T. Nolan, F. Shann
- Journal of paediatrics and child health
- 1 June 2002
Objectives: To consider the worldwide prevalence of rheumatic heart disease in children in developing countries using surveys with uniform methodologies, and to consider the effect of environmental… Expand
Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren
- J. Carapetis, Myra Hardy, +4 authors A. Steer
- Nature Clinical Practice Cardiovascular Medicine
- 1 July 2008
Screening is a useful method for detecting asymptomatic RHD in regions of high prevalence and it is reported that a high echocardiographically confirmed prevalence is reported in Tonga. Expand